Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3744024)

Published in J Cell Sci on June 26, 2013

Authors

Rob Goold1, Chris McKinnon, Samira Rabbanian, John Collinge, Giampietro Schiavo, Sarah J Tabrizi

Author Affiliations

1: Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.

Articles citing this

Autophagy protects against de novo formation of the [PSI+] prion in yeast. Mol Biol Cell (2015) 1.45

Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci (2013) 1.09

The multivesicular body is the major internal site of prion conversion. J Cell Sci (2015) 0.81

Axonal and transynaptic spread of prions. J Virol (2014) 0.80

A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes. J Biol Chem (2014) 0.80

Shedding light on prion disease. Prion (2015) 0.79

Human prion protein-induced autophagy flux governs neuron cell damage in primary neuron cells. Oncotarget (2016) 0.78

Protein homeostasis at the plasma membrane. Physiology (Bethesda) (2014) 0.78

Prion protein-specific antibodies-development, modes of action and therapeutics application. Viruses (2014) 0.78

Prion degradation pathways: Potential for therapeutic intervention. Mol Cell Neurosci (2015) 0.78

Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system. Acta Neuropathol (2015) 0.77

Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes. Am J Pathol (2013) 0.77

PrP knockout cells expressing transmembrane PrP resist prion infection. J Virol (2016) 0.76

The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders. Neurotherapeutics (2015) 0.75

Transcriptomic Determinants of Scrapie Prion Propagation in Cultured Ovine Microglia. PLoS One (2016) 0.75

Prions amplify through degradation of the VPS10P sorting receptor sortilin. PLoS Pathog (2017) 0.75

Prion strains depend on different endocytic routes for productive infection. Sci Rep (2017) 0.75

Articles cited by this

Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23

Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J Cell Biol (2001) 4.22

Retromer. Curr Opin Cell Biol (2008) 3.89

Protein quality control in the early secretory pathway. EMBO J (2008) 3.59

Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature (2012) 3.54

Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46

Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23

Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol (1998) 3.07

Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science (2002) 3.05

A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A (2003) 2.94

Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron (2006) 2.76

Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67

Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell (2010) 2.67

The state of the prion. Nat Rev Microbiol (2004) 2.60

Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A (2001) 2.53

Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem (1997) 2.48

Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J (2003) 2.34

Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14

Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell (2009) 2.14

Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci U S A (2008) 2.09

Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04

Biotinylation and assessment of membrane polarity: caveats and methodological concerns. Am J Physiol (1995) 2.02

Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01

The intracellular voyage of cholera toxin: going retro. Trends Biochem Sci (2003) 1.93

Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci (2005) 1.85

Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic (2002) 1.84

Mechanisms controlling EGF receptor endocytosis and degradation. Biochem Soc Trans (2003) 1.71

Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature. Cell Tissue Res (2005) 1.66

Identification of an intracellular site of prion conversion. PLoS Pathog (2009) 1.61

Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Dev Cell (2008) 1.54

A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol (2006) 1.54

Autophagy induction by trehalose counteracts cellular prion infection. Autophagy (2009) 1.46

Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem (2005) 1.42

The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J Pathol (1995) 1.40

Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J (2001) 1.29

Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells. J Biol Chem (2002) 1.25

Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog (2009) 1.22

Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res (1994) 1.16

Assembly and disassembly of the Golgi complex: two processes arranged in a cis-trans direction. J Cell Biol (1992) 1.15

LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci (2008) 1.15

Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem (2002) 1.14

Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Eur J Cell Biol (2008) 1.14

Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J Biol Chem (2002) 1.08

The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines. Eur J Neurosci (2005) 1.07

Involvement of the endosomal-lysosomal system correlates with regional pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (2007) 0.99

Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. J Neurosci (2005) 0.99

Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells. J Virol (2004) 0.99

Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit. Neuron (2012) 0.96

Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J Gen Virol (2003) 0.95

Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem (2011) 0.94

Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4. J Cell Sci (2010) 0.94

Articles by these authors

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol (2011) 4.98

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science (2003) 4.57

Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40

Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet (2005) 4.21

Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet (2006) 3.12

BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J (2002) 2.98

Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science (2004) 2.82

Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron (2006) 2.79

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med (2008) 2.78

Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature (2011) 2.74

Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65

Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet (2011) 2.60

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron (2007) 2.58

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57

Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol (2013) 2.42

Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain (2003) 2.42

Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol (2009) 2.37

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One (2008) 2.33

Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature (2003) 2.31

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30

A systematic review of prion therapeutics in experimental models. Brain (2006) 2.25

A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain (2008) 2.13

Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet (2013) 2.09

Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01

A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol (2005) 2.01

Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2). Biochem J (2009) 2.00

Purification and characterization of the human elongator complex. J Biol Chem (2001) 1.97

Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron (2009) 1.96

Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet (2004) 1.96

Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun (2011) 1.96

Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol (2009) 1.94

Microglial activation in presymptomatic Huntington's disease gene carriers. Brain (2007) 1.93

Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci (2010) 1.92

Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures. Science (2005) 1.92

Variant CJD in an individual heterozygous for PRNP codon 129. Lancet (2009) 1.84

Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J (2008) 1.77

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients. J Clin Invest (2015) 1.74

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71

A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med (2013) 1.69

Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66

ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc Natl Acad Sci U S A (2011) 1.60

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res (2007) 1.59

SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem Sci (2005) 1.58

A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med (2009) 1.53

Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum Mol Genet (2005) 1.51

White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain (2007) 1.47

Update on human prion disease. Biochim Biophys Acta (2007) 1.46

Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr (2010) 1.45

Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors. Brain (2011) 1.45

Molecular and clinical classification of human prion disease. Br Med Bull (2003) 1.45

Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem (2005) 1.42

Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol (2004) 1.42

Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol (2013) 1.41

The Prevalence of Huntington's Disease. Neuroepidemiology (2016) 1.40

A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol (2010) 1.39

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Mapp (2011) 1.39

Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. J Cell Biol (2002) 1.38

Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein. Emerg Infect Dis (2013) 1.38

Long chain polyunsaturated fatty acids are required for efficient neurotransmission in C. elegans. J Cell Sci (2003) 1.38

Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A (2008) 1.37

Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain (2003) 1.37

Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris (2001) 1.36

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood (2013) 1.36

Subclinical prion infection. Trends Microbiol (2003) 1.36

Huntington's disease. BMJ (2010) 1.36

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci U S A (2007) 1.35

Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet (2010) 1.35

CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog (2009) 1.35

The role of CHMP2B in frontotemporal dementia. Biochem Soc Trans (2009) 1.34

Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain (2006) 1.34

Interaction of tau protein with the dynactin complex. EMBO J (2007) 1.33

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp (2011) 1.32

Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics (2002) 1.31

Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain (2006) 1.31

Coordinated regulation of AP2 uncoating from clathrin-coated vesicles by rab5 and hRME-6. J Cell Biol (2008) 1.31

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry (2013) 1.30

The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain (2013) 1.26

Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet (2011) 1.25

Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One (2010) 1.25

Subclinical prion infection in humans and animals. Br Med Bull (2003) 1.25

The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem (2007) 1.23

Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol (2004) 1.23

Molecular landmarks along the axonal route: axonal transport in health and disease. Curr Opin Cell Biol (2008) 1.23

Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol (2006) 1.23

The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol (2003) 1.23

Spastin and microtubules: Functions in health and disease. J Neurosci Res (2007) 1.22

Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A (2006) 1.22

Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol Cell Biol (2005) 1.21

Targets for future clinical trials in Huntington's disease: what's in the pipeline? Mov Disord (2014) 1.21

Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol (2008) 1.20

Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. J Cell Sci (2003) 1.20